Publication: COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP.
Loading...
Identifiers
Date
2022
Authors
Busca, Alessandro
Salmanton-García, Jon
Corradini, Paolo
Marchesi, Francesco
Cabirta, Alba
Di Blasi, Roberta
Dulery, Remy
Lamure, Sylvain
Farina, Francesca
Weinbergerová, Barbora
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The EHA-IDWP developed an observational registry collecting data on COVID-19 infection in patients who received CAR T-cell therapy. Prevalence of COVID-19 was 4.8%, and overall mortality was 50%, highlighting the need for prevention of infection in these patients.
Description
MeSH Terms
COVID-19
Humans
Immunotherapy, Adoptive
Receptors, Chimeric Antigen
T-Lymphocytes
Humans
Immunotherapy, Adoptive
Receptors, Chimeric Antigen
T-Lymphocytes